| 3.31 Data as of 3:09pm ET |  +0.03 / +0.91%Today’s Change | 3.10 Today|||52-Week Range 11.76 | -38.13% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $7.5M |
Oxigene, Inc. 701 Gateway Boulevard South San Francisco California 94080 |
| Other institutional | 10.52% |
| Individual stakeholders | 0.56% |
| Mutual fund holders | 0.29% |
| Peter J. Langecker, MD, PhD | Chairman, President & Chief Executive Officer |
| Barbara Riching, CPA | Chief Financial Officer |
| Jai Balkissoon, MD | Vice President-Clinical Development |
| Kathleen M. Lee, PhD, MBA | Vice President-Chemistry, Manufacturing & Controls |
| Alice M. Varga | VP-Regulatory Affairs & Quality Assurance |
.
